Results 91 to 100 of about 2,566,443 (193)
ABSTRACT Background Lifestyle interventions targeting metabolic health may influence chronic kidney disease (CKD) risk, particularly among adults with type 2 diabetes and obesity. We evaluated real‐world associations between a telehealth‐delivered, individualized nutrition therapy program (VINT) and CKD incidence and progression compared with usual ...
Shaminie J. Athinarayanan +7 more
wiley +1 more source
The genetics of gout: towards personalised medicine?
Over the last decade, there have been major advances in the understanding of the genetic basis of hyperuricaemia and gout as well as of the pharmacogenetics of urate-lowering therapy.
Nicola Dalbeth +2 more
doaj +1 more source
Background Gout, characterized by monosodium urate crystal deposition, rarely involves the nasal septum, with only a few reported cases. Such unusual presentations can mimic other conditions, necessitating prompt and accurate diagnosis.
Weikun Chen +5 more
doaj +1 more source
Battle of the strategies: diet versus drug therapy for gout
The best results in combating gout are achieved through a combination of diet and drug therapy. Urate-lowering therapy, which includes febuxostat, has been shown to be more effective and convenient than diet when it comes to achieving and maintaining ...
O. V. Zhelyabina +2 more
doaj +1 more source
Uricases: reflections on recent developments in the management of challenging gout patients [PDF]
Oral urate-lowering therapy (ULT) is key to treating gout. However, many patients receiving oral ULT do not achieve the target serum urate (SU) levels, partly because some patients cannot tolerate or have contraindications to their use, mainly due to ...
Naomi Schlesinger, Dan Kaufmann
doaj +1 more source
Schematic of the samples selection process for association between urate-lowering therapy and risk of type 2 diabetes mellitus.
Hsin-Wen Chang (216673) +4 more
core +1 more source
[Objective] To evaluate the efficacy and safety of the single-use hemoperfusion device (UA230) in treating refractory gout (RG) via plasma perfusion. [Methods] Thirty-four RG patients aged 18-65 years were recruited and randomly divided into a control ...
LI Ying +6 more
doaj +1 more source
Graeme Jones,1 Elena Panova,1 Richard Day2 1Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; 2University of New South Wales, Medicine, St Vincent’s Hospital, Sydney, NSW, Australia Abstract: The aim of this ...
Jones G, Panova E, Day R
doaj
Treatment of Gout in Patients with CrCl ≤30 mL/min and/or on Hemodialysis: A Review
Gout is highly prevalent in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), owing to impaired uric acid excretion. However, treating gout in this population is challenging due to concerns about medication safety and ...
Fares Saliba +10 more
doaj +1 more source
Hyperuricaemia is highly prevalent in patients with chronic kidney disease (CKD), primarily due to reduced renal urate excretion. Elevated serum uric acid (SUA) levels have been linked with CKD progression, cardiovascular disease, and mortality. However,
Sourabh Sharma +3 more
doaj +1 more source

